Interestingly, recent data have suggested that the polymorphism of various genes, including the PPAR-gamma, IL-28B, adiponutrin and microsomal triglyceride transfer protein (MTP) genes, may influence the development of more severe steatosis in chronic carriers of HCV [30]–[34]. The gene discussed is PPARG; the disease is steatosis.